Jiang, M C <br/><br/>
Synergic CSE1L/CAS, TNFR-1, and p53 apoptotic pathways in combined interferon-gamma/adriamycin-induced apoptosis of Hep G2 hepatoma cells.  [electronic resource] 

 -  Journal of experimental & clinical cancer research : CR  Mar 2007 
 - 91-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0392-9078 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Carcinoma, Hepatocellular--metabolism<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cellular Apoptosis Susceptibility Protein--metabolism<br/>Dose-Response Relationship, Drug<br/>Doxorubicin--pharmacology<br/>Drug Synergism<br/>Etoposide--pharmacology<br/>Humans<br/>Interferon Regulatory Factor-1--genetics<br/>Interferon-gamma--pharmacology<br/>Liver Neoplasms--metabolism<br/>Receptors, Tumor Necrosis Factor, Type I--metabolism<br/>Signal Transduction--drug effects<br/>Transfection<br/>Tumor Suppressor Protein p53--metabolism<br/>bcl-2-Associated X Protein--metabolism<br/>bcl-Associated Death Protein--metabolism